Abstract
Aim: This study aimed to formulate and characterize aceclofenac buccal film formulations made of different polymers and evaluate the effects of polymer type on buccal film properties.
Materials and Methods: Five polymer types, namely hydroxypropyl methylcellulose (HPMC), sodium carboxymethylcellulose (SCMC), polyvinyl alcohol (PVA), Eudragit S100, and Eudragit SR100, were used to prepare aceclofenac buccal film formulation either separately or combined by solvent-casting method. These formulations were evaluated in terms of physical appearance, folding test, film weight and thickness, drug content, percentage of elongation, moisture uptake, water vapor permeability, and in vitro drug release.
Results: The addition of Eudragit polymer in most of the produced buccal films was unacceptable with low folding endurance. However, the dissolution profile of buccal films made from PVA and Eudragit SR100 provided a controlled drug release profile.
Conclusion: Buccal films can be formulated using different polymers either individually or in combination to obtain the drug release profile required to achieve a desired treatment goal. Furthermore, the property of the buccal films depends on the type and concentration of the polymer used.
Graphical Abstract
[1]
Alopaeus JF. Mucoadhesive buccal films based on a graft co-polymer-A mucin-retentive hydrogel scaffold. Eur J Pharm Sci 2020; 142: 105142.
[http://dx.doi.org/10.1016/j.ejps.2019.105142]
[http://dx.doi.org/10.1016/j.ejps.2019.105142]
[2]
Abd El Azim H, Nafee N, Ramadan A, Khalafallah N. Liposomal buccal mucoadhesive film for improved delivery and permeation of water-soluble vitamins. Int J Pharm 2015; 488(1-2): 78-85.
[http://dx.doi.org/10.1016/j.ijpharm.2015.04.052] [PMID: 25899288]
[http://dx.doi.org/10.1016/j.ijpharm.2015.04.052] [PMID: 25899288]
[3]
Santosh K, Prabin N, Govinda G, et al. Formulation and evaluation of mucoadhesive buccal tablets of aceclofenac. Heliyon 2021; 7(3): e06439.
[http://dx.doi.org/10.1016/j.heliyon.2021.e06439]
[http://dx.doi.org/10.1016/j.heliyon.2021.e06439]
[4]
Okafor NI, Ngoepe M, Noundou XS, Krause R W M. Nano-enabled liposomal mucoadhesive films for enhanced efavirenz buccal drug delivery. J Drug Deliv Sci Technol 2019; 54: 101312.
[5]
Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J Control Release 2013; 166(1): 10-21.
[http://dx.doi.org/10.1016/j.jconrel.2012.11.019]
[http://dx.doi.org/10.1016/j.jconrel.2012.11.019]
[6]
Shipp L, Liu F, Kerai-Varsani L, Okwuosa TC. Buccal films: A review of therapeutic opportunities, formulations & relevant evaluation approaches. J Control Release 2022; 352: 1071-92.
[http://dx.doi.org/10.1016/j.jconrel.2022.10.058] [PMID: 36351519]
[http://dx.doi.org/10.1016/j.jconrel.2022.10.058] [PMID: 36351519]
[7]
Salehi S, Boddohi S. New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate. Prog Biomater 2017; 6(4): 175-87.
[8]
Rezvanian M, Amin MCIM, Ng S-F. Development and physicochemical characterization of alginate composite film loaded with simvastatin as a potential wound dressing. Carbohydr Polym 2016; 137: 295-304.
[9]
Almurisi SH, Akkawi ME, Chatterjee B, Sarker MZI. Taste masking of paracetamol encapsulated in chitosan-coated alginate beads. J Drug Deliv Sci Technol 2020; 56: 101520.
[10]
Shiledar RR, Tagalpallewar AA, Kokare CR. Formulation and in vitro evaluation of xanthan gum-based bilayered mucoadhesive buccal patches of zolmitriptan. Carbohydr Polym 2014; 101: 1234-42.
[11]
Abo Enin HA, El Nabarawy NA, Elmonem RAA. Treatment of radiation-induced oral mucositis using a novel accepted taste of prolonged release mucoadhesive bi-medicated double-layer buccal films. AAPS PharmSciTech 2017; 18(2): 563-75.
[http://dx.doi.org/10.1208/s12249-016-0533-z] [PMID: 27138037]
[http://dx.doi.org/10.1208/s12249-016-0533-z] [PMID: 27138037]
[12]
Ain Qu, Zaman M, Jamshaid M, et al. Optimization and evaluation of instant release buccal films of eletriptan: A quality-by-design approach. Polym Bull 2022; 80: 10429-55.
[13]
Tejada G, Lamas M, Svetaz L, Salomón C, Alvarez V, Leonardi D. Effect of drug incorporation technique and polymer combination on the performance of biopolymeric antifungal buccal films. Int J Pharm 2018; 548(1): 431-42.
[http://dx.doi.org/10.1016/j.ijpharm.2018.07.023]
[http://dx.doi.org/10.1016/j.ijpharm.2018.07.023]
[14]
Abouhussein D, El Nabarawi MA, Shalaby SH, Abd El-Bary A. Cetylpyridinium chloride chitosan blended mucoadhesive buccal films for treatment of pediatric oral diseases. J Drug Deliv Sci Technol 2020; 57: 101676.
[15]
Karki S, Kim H, Na S-J, Shin D, Jo K, Lee J. Thin films as an emerging platform for drug delivery. Asian J Pharmaceut Sci 2016; 11(5): 559-74.
[http://dx.doi.org/10.1016/j.ajps.2016.05.004]
[http://dx.doi.org/10.1016/j.ajps.2016.05.004]
[16]
Preis M, Woertz C, Kleinebudde P, Breitkreutz J. Oromucosal film preparations: Classification and characterization methods. Expert Opin Drug Deliv 2013; 10(9): 1303-7.
[17]
Jovanović M, Petrović M, Cvijić S, et al. 3d printed buccal films for prolonged-release of propranolol hydrochloride: Development, characterization and bioavailability prediction. Pharmaceutics 2021; 13(12): 2143.
[http://dx.doi.org/10.3390/pharmaceutics13122143] [PMID: 34959423]
[http://dx.doi.org/10.3390/pharmaceutics13122143] [PMID: 34959423]
[18]
Falath W, Sabir A, Jacob KI. Novel reverse osmosis membranes composed of modified PVA/Gum Arabic conjugates: Biofouling mitigation and chlorine resistance enhancement. Carbohydr Polym 2017; 155: 28-39.
[19]
Kelemen A. Effects of sucrose palmitate on the physico-chemical and mucoadhesive properties of buccal films. Molecules 2020; 25(22): 5248.
[http://dx.doi.org/10.3390/molecules25225248]
[http://dx.doi.org/10.3390/molecules25225248]
[20]
Hua S. Advances in nanoparticulate drug delivery approaches for sublingual and buccal administration. Front Pharmacol 2019; 10: 1328.
[http://dx.doi.org/10.3389/fphar.2019.01328]
[http://dx.doi.org/10.3389/fphar.2019.01328]
[21]
Gittings S, Turnbull N, Henry B, Roberts CJ, Gershkovich P. Characterisation of human saliva as a platform for oral dissolution medium development. Eur J Pharm Biopharm 2015; 91: 16-24.
[22]
Jillani U. Design and characterization of Agarose/HPMC buccal films bearing ondansetron HCl in vitro and in Vivo: Enhancement using iontophoretic and chemical approaches. Biomed Res Int 2022; 2022: 1662194.
[23]
Rohani Shirvan A, Bashari A, Hemmatinejad N. New insight into the fabrication of smart mucoadhesive buccal patches as a novel controlled-drug delivery system. Eur Polym J 2019; 119: 541-50.
[http://dx.doi.org/10.1016/j.eurpolymj.2019.07.010]
[http://dx.doi.org/10.1016/j.eurpolymj.2019.07.010]
[24]
Preis M, Breitkreutz J, Sandler N. Perspective: Concepts of printing technologies for oral film formulations. Int J Pharm 2015; 494(2): 578-84.
[25]
Godbole A, Joshi R, Sontakke M, Sciences A. Oral thin film technology-current challenges and future scope. Int J Adv Res Eng Appl Sci 2018; 7(2): 14.
[26]
He M, Zhu L, Yang N, Li H, Yang Q. Recent advances of oral film as platform for drug delivery. Int J Pharm 2021; 604: 120759.
[http://dx.doi.org/10.1016/j.ijpharm.2021.120759]
[http://dx.doi.org/10.1016/j.ijpharm.2021.120759]
[27]
Montenegro-Nicolini M, Morales JO. Overview and future potential of buccal mucoadhesive films as drug delivery systems for biologics. AAPS PharmSciTech 2017; 18(1): 3-14.
[28]
Nair VV, Cabrera P, Ramírez-Lecaros C, Jara MO, Brayden DJ, Morales JO. Buccal delivery of small molecules and biologics: Of mucoadhesive polymers, films, and nanoparticles - An update. Int J Pharm 2023; 636: 122789.
[http://dx.doi.org/10.1016/j.ijpharm.2023.122789] [PMID: 36868332]
[http://dx.doi.org/10.1016/j.ijpharm.2023.122789] [PMID: 36868332]
